Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 1,127,835 | $112,806,029.00 | 5.22% |
Novo Nordisk AS, Class B | Equity | 629,450 | $74,950,669.00 | 3.47% |
SAP SE | Equity | 289,144 | $65,682,331.00 | 3.04% |
Safran SA | Equity | 261,721 | $61,753,284.00 | 2.86% |
AstraZeneca PLC | Equity | 347,911 | $54,192,303.00 | 2.51% |
ASML Holding NV | Equity | 60,240 | $50,219,057.00 | 2.33% |
TotalEnergies SE | Equity | 749,620 | $48,586,844.00 | 2.25% |
London Stock Exchange Group PLC | Equity | 348,689 | $47,676,588.00 | 2.21% |
Taiwan Semiconductor Manufacturing Co., Ltd. (ADR) | Equity | 254,562 | $44,209,783.00 | 2.05% |
Rolls-Royce Holdings PLC | Equity | 5,102,346 | $36,034,333.00 | 1.67% |
L'Oreal SA, non-registered shares | Equity | 78,294 | $35,099,488.00 | 1.63% |
EssilorLuxottica SA | Equity | 147,868 | $35,038,841.00 | 1.62% |
Sika AG | Equity | 102,764 | $34,093,909.00 | 1.58% |
Amadeus IT Group SA, Class A, non-registered shares | Equity | 468,188 | $33,792,926.00 | 1.56% |
Keyence Corp. | Equity | 69,020 | $33,036,544.00 | 1.53% |